Chicago-based CRISPR technology company Syntax Bio says it has developed tech that automates the slow, manual process of generating functional cell types, which may usher in a new generation of cell ...
As buzzwords like “holistic care” and “patient-centric” have solidified into value-based care models and total capitation contracts, providers and payers still face a lot of friction to align ...
Acquisition strengthens Lightbeam's AI-enabled operating system for value-based care by integrating Syntax's innovative incentive modeling platform and adds actuarial services DALLAS, Dec. 4, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback